UBS Upgrades Ionis Pharmaceuticals (IONS) to Neutral (friday)
Tweet Send to a Friend
UBS analyst Esther Rajavelu upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
